Autologous Platelet-rich Plasma for Clomiphene Citrate-induced Thin Endometrium

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

January 1, 2020

Conditions
Infertility, Female, Associated With Anovulation
Interventions
DRUG

clomiphene citrate

Clomiphene citrate-only arm: Patients will receive Clomiphene citrate induction (in a dose of 100 mg/day starting from day 3 of the cycle for 5 days). Sonographic assessment of endometrial thickness together with Power Doppler evaluation endometrial and sub-endometrial blood flow a will be done in the Day of HCG injection.

DRUG

Saline cervical flushing

Cervical irrigation with 1 ml of 0.9% normal saline will be done at cycle day 8 and 10 to convince patient-blinded procedure.

BIOLOGICAL

Intrauterine Autologous platelet-rich plasma

Under complete aseptic cares and ultrasound supervision, Autologous platelet-rich plasma (0.5 - 1 ml) was immediately injected into the uterine cavity using an intrauterine insemination catheter in the cycle days 8 and 10. The Autologous platelet-rich plasma is prepared in collaboration with the Department of Clinical Pathology, Faculty of Medicine, Benha University.

Trial Locations (1)

13511

Banha Faculty Hospital, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT03770026 - Autologous Platelet-rich Plasma for Clomiphene Citrate-induced Thin Endometrium | Biotech Hunter | Biotech Hunter